DE68916359T2 - Arylendiamin-substituierte Pyrimidine. - Google Patents

Arylendiamin-substituierte Pyrimidine.

Info

Publication number
DE68916359T2
DE68916359T2 DE68916359T DE68916359T DE68916359T2 DE 68916359 T2 DE68916359 T2 DE 68916359T2 DE 68916359 T DE68916359 T DE 68916359T DE 68916359 T DE68916359 T DE 68916359T DE 68916359 T2 DE68916359 T2 DE 68916359T2
Authority
DE
Germany
Prior art keywords
substituted pyrimidines
arylenediamine
substituents
alkyl
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68916359T
Other languages
English (en)
Other versions
DE68916359D1 (de
Inventor
Edward Lockwood Wheeler
Robert John Franko
Franklin Herbert Barrows
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Uniroyal Chemical Co Inc
Original Assignee
Uniroyal Chemical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniroyal Chemical Co Inc filed Critical Uniroyal Chemical Co Inc
Publication of DE68916359D1 publication Critical patent/DE68916359D1/de
Application granted granted Critical
Publication of DE68916359T2 publication Critical patent/DE68916359T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50Three nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/16Nitrogen-containing compounds
    • C08K5/34Heterocyclic compounds having nitrogen in the ring
    • C08K5/3442Heterocyclic compounds having nitrogen in the ring having two nitrogen atoms in the ring
    • C08K5/3462Six-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE68916359T 1988-09-21 1989-08-30 Arylendiamin-substituierte Pyrimidine. Expired - Fee Related DE68916359T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/247,143 US4946956A (en) 1988-09-21 1988-09-21 Arylenediamine substituted pyrimidines

Publications (2)

Publication Number Publication Date
DE68916359D1 DE68916359D1 (de) 1994-07-28
DE68916359T2 true DE68916359T2 (de) 1994-10-27

Family

ID=22933755

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68916359T Expired - Fee Related DE68916359T2 (de) 1988-09-21 1989-08-30 Arylendiamin-substituierte Pyrimidine.

Country Status (7)

Country Link
US (1) US4946956A (de)
EP (1) EP0363002B1 (de)
KR (1) KR0120735B1 (de)
AT (1) ATE107635T1 (de)
BR (1) BR8904702A (de)
CA (1) CA1339846C (de)
DE (1) DE68916359T2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69933680T2 (de) 1998-08-29 2007-08-23 Astrazeneca Ab Pyrimidine verbindungen
JP2002523498A (ja) 1998-08-29 2002-07-30 アストラゼネカ・アクチエボラーグ ピリミジン化合物
GB9828511D0 (en) 1998-12-24 1999-02-17 Zeneca Ltd Chemical compounds
GB9905075D0 (en) 1999-03-06 1999-04-28 Zeneca Ltd Chemical compounds
GB9907658D0 (en) 1999-04-06 1999-05-26 Zeneca Ltd Chemical compounds
GB9919778D0 (en) 1999-08-21 1999-10-27 Zeneca Ltd Chemical compounds
GB0004886D0 (en) 2000-03-01 2000-04-19 Astrazeneca Uk Ltd Chemical compounds
GB0004890D0 (en) 2000-03-01 2000-04-19 Astrazeneca Uk Ltd Chemical compounds
GB0004887D0 (en) 2000-03-01 2000-04-19 Astrazeneca Uk Ltd Chemical compounds
GB0004888D0 (en) 2000-03-01 2000-04-19 Astrazeneca Uk Ltd Chemical compounds
US6646029B1 (en) * 2000-03-21 2003-11-11 Flexsys America L.P. Pyrimidine derivatives as hardness stabilizers
US6465604B2 (en) 2000-03-21 2002-10-15 Flexsys America L.P. Pyrimidine derivatives as hardness stabilizers
GB0007371D0 (en) 2000-03-28 2000-05-17 Astrazeneca Uk Ltd Chemical compounds
GB0016877D0 (en) 2000-07-11 2000-08-30 Astrazeneca Ab Chemical compounds
GB0021726D0 (en) 2000-09-05 2000-10-18 Astrazeneca Ab Chemical compounds
CZ20032341A3 (cs) * 2001-01-31 2004-12-15 Synaptic Pharmaceutical Corporation Použití antagonistů GAL3 receptoru pro léčbu deprese a/nebo úzkosti
US7081470B2 (en) * 2001-01-31 2006-07-25 H. Lundbeck A/S Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
WO2002060392A2 (en) * 2001-01-31 2002-08-08 Synaptic Pharmaceutical Corporation Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
US20040127502A1 (en) * 2001-01-31 2004-07-01 Synaptic Pharmaceutical Corporation Use of GAL3 antagonist for treatment of depression
GB0103926D0 (en) 2001-02-17 2001-04-04 Astrazeneca Ab Chemical compounds
GB0113041D0 (en) 2001-05-30 2001-07-18 Astrazeneca Ab Chemical compounds
GB0205688D0 (en) 2002-03-09 2002-04-24 Astrazeneca Ab Chemical compounds
GB0205693D0 (en) 2002-03-09 2002-04-24 Astrazeneca Ab Chemical compounds
GB0205690D0 (en) 2002-03-09 2002-04-24 Astrazeneca Ab Chemical compounds
AU2003208479A1 (en) 2002-03-09 2003-09-22 Astrazeneca Ab 4- imidazolyl substuited pyrimidine derivatives with cdk inhibitiory activity
US6936607B2 (en) * 2002-08-07 2005-08-30 H. Lunobeck A/S 2,4,6-Triaminopyrimidines for the treatment of depression and/or anxiety
GB0311274D0 (en) 2003-05-16 2003-06-18 Astrazeneca Ab Chemical compounds
GB0311276D0 (en) 2003-05-16 2003-06-18 Astrazeneca Ab Chemical compounds
TW200528101A (en) 2004-02-03 2005-09-01 Astrazeneca Ab Chemical compounds
UY29826A1 (es) 2005-09-30 2007-04-30 Astrazeneca Ab Derivados de pirimidina, sales farmaceuticamente aceptables, esteres de los mismos hidrolisables in vivo, procesos de preparacion y aplicaciones

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3206398A1 (de) * 1982-02-23 1983-09-01 Basf Ag, 6700 Ludwigshafen S-triazinderivate und ihre verwendung als lichtschutzmittel
US4650867A (en) * 1985-03-26 1987-03-17 Ciba-Geigy Corporation Process for the preparation of 2,4,6-tris(aminophenylamino)triazines
US4786672A (en) * 1986-07-31 1988-11-22 Ciba-Geigy Corporation Anilinotriazines and the use thereof
US4794134A (en) * 1987-08-28 1988-12-27 Uniroyal Chemical Company, Inc. Ozone resistant elastomeric articles
JPH033982A (ja) * 1989-05-31 1991-01-10 Matsushita Electric Works Ltd エアーポンプ

Also Published As

Publication number Publication date
KR0120735B1 (ko) 1997-10-30
BR8904702A (pt) 1990-05-01
ATE107635T1 (de) 1994-07-15
DE68916359D1 (de) 1994-07-28
US4946956A (en) 1990-08-07
EP0363002B1 (de) 1994-06-22
CA1339846C (en) 1998-04-28
EP0363002A1 (de) 1990-04-11
KR900004700A (ko) 1990-04-12

Similar Documents

Publication Publication Date Title
ATE107635T1 (de) Arylendiamin-substituierte pyrimidine.
FI915920A (fi) Serotoninantagonister.
PT778277E (pt) Derivados heterociclicos substituidos como antagonistas do crf
ATE168992T1 (de) 7-substituierte-9-substituierte glycylamido-6- demethyl-6-deoxytetracycline
ATA85893A (de) Nicht-wandernde 1-hydrocarbyloxy-2,2,6,6- tetramethylpiperidin-1,3,5-triazinderivate als polymerstabilisatoren
NO962059L (no) Antiarytmiske benzodiazepiner
ES2161220T3 (es) 9-((glicil sustituido)amido)-6-desmetil-6-desoxitetraciclinas como agentes antibioticos.
ATE26835T1 (de) Tris(piperidylaminotriazylamino) verbindungen, ihre herstellung und ihre verwendung als stabilisierungsmittel fuer polymere.
TW207533B (de)
MX9302931A (es) Nuevas 4-aza-5&-colestan-onas 7b-substituidas como inhibidores de 5&-reductasa.
MY105344A (en) New sulphonyl compounds
DE3067072D1 (en) Novel substituted arylene compounds and processes for their production
ES2110213T3 (es) Derivado de n-acilglutamina.
ES2099013A1 (es) Nuevos compuestos de polimetilpiperidina con grupos de silano y su uso como estabilizantes para materiales organicos.
ATE89003T1 (de) Dioxaphosphorin-verbindungen und damit stabilisierte polyolefin-zusammensetzungen.
ATE156486T1 (de) Fungizide 3,4-diaryl-(5h)-furan-2-onederivate
DK0475367T3 (da) Amelin-derivater og selvslukkende polymersammensætninger indeholdende disse
ATE112768T1 (de) Triazinverbindungen.
DE59404557D1 (de) Hetero-tricyclisch-substituierte Phenyl-cyclohexan-carbonsäurederivate
ITMI930819A1 (it) Derivati eterobiciclici ad attivita' fungicida
BR9407232A (pt) Compostos de tiocarbamoíla
DE69316903T2 (de) Saintopin derivate
ATE158293T1 (de) Polycyclische 31668p- und 31668u-verbindungen, verfahren zu ihrer herstellung und ihre verwendung als antibiotische oder antitumorale arzneistoffe
ATE127803T1 (de) Mitomycinderivate.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee